Objectives: To analyse the in vitro transfer of the qnrA1 gene by a 50 kb (pSZ50) self-transferable plasmid that derives from a 300 kb plasmid (pSZ300) and to determine the complete nucleotide sequence of plasmid pSZ50.
Introduction
Plasmids are key vectors for horizontal gene transfer among bacteria, and they often carry antibiotic resistance genes. The dissemination of multidrug-resistant bacteria harbouring genes that encode extended-spectrum b-lactamases (ESBLs), carbapenemases and plasmid-mediated quinolone resistance (PMQR) is increasingly reported worldwide. 1 Plasmid-mediated resistance to quinolones was initially identified in a Klebsiella pneumoniae clinical isolate. 2 The qnr genes encode Qnr proteins belonging to the pentapeptide repeat protein family. 3 The resistance mechanism consists of the protection of DNA gyrase from the action of quinolone interaction. 4 To date, five qnr families have been described: qnrA, qnrB, qnrC, qnrD and qnrS (http: //www.lahey.org/qnrStudies). Moreover, two additional PMQR genes have been identified: aac(6 ′ )-Ib-cr that encodes an aminoglycoside acetyltransferase variant capable of modifying ciprofloxacin and norfloxacin, 5 and qepA that encodes an efflux pump belonging to the major facilitator superfamily. 6 In this article we report the in vitro transfer of the qnrA1 gene by a 50 kb self-transferable plasmid that derives from the 300 kb plasmid pSZ300.
Materials and methods
Bacterial strain and antimicrobial susceptibility testing ESBL-producing Escherichia coli clinical isolate 5509 was obtained from the urine of an inpatient at the Instituto Nacional de Ciencias Médicas y Nutrició n 'Salvador Zubiran' (INCMNSZ) in 2004. The production of ESBLs was identified using the disc diffusion method with cefotaxime and ceftazidime alone and in combination with clavulanic acid, as recommended by the CLSI. 7 The MICs of nalidixic acid, ciprofloxacin, levofloxacin, ceftazidime, ceftazidime/clavulanic acid, cefotaxime and gentamicin were determined by the microdilution method according to the CLSI guidelines. 7 Resistance genotype characterization ESBL genes were searched for by PCR, using specific primers for genes encoding SHV-, CTX-M-and TLA-type b-lactamases. 8 The PMQR genes [qnrA, qnrB, qnrS, aac(6 ′ )-Ib-cr and qepA] as well as the mutations of the gyrA and parC genes were screened by PCR using specific primers (Table S1 , available as Supplementary data at JAC Online). The chain termination method was used to sequence all PCR products with a Big Dye Terminator kit (Applied Biosystems, Foster City, CA, USA) and they were analysed on an ABI PRISM 3100 (Applied Biosystems).
Bacterial conjugation and plasmid analysis
Two mating-out experiments at 30 and 378C were carried out according to the method of Miller. 9 The first mating (F1) was performed with E. coli 5509 as the donor strain and E. coli J53 (sodium azide resistant) as the recipient. The selection was performed on Luria agar supplemented with sodium azide (150 mg/L) and nalidixic acid (8 mg/L), ciprofloxacin (0.5 mg/L), ampicillin (100 mg/L), cefotaxime (1 mg/L), tetracycline (15 mg/L), chloramphenicol (10 mg/L) or gentamicin (16 mg/L). The second mating (F2) was carried out with two different transconjugants, F1-A and F1-B, as the donor strains and E. coli J53-3 or E. coli J53-2 (rifampicin resistant) as the recipient. Transconjugants were selected on Luria agar supplemented with rifampicin (100 mg/L) and cefotaxime (1 mg/L), tetracycline (100 mg/L) or nalidixic acid (8 mg/L). All putative transconjugants were verified by their auxotrophic requirements (Pro and Met) and antimicrobial resistance phenotypes in eight antibiotics. Plasmid contents were analysed according to the method described by Kieser. 10 Plasmids R6K (40 kb), RP4 (54 kb), R1 (94), pMG229 (205 kb) and pUD21 (275 kb) were used as molecular size markers.
Analysis of plasmid splitting by Southern hybridization and incompatibility group identification
The plasmid preparations obtained by means of ion exchange columns (Qiagen, Valencia, CA, USA) from E. coli isolate 5509 and F1-A and F1-B transconjugants were digested with the EcoRI restriction enzyme and separated in a 0.7% agarose gel. A probe was obtained from the qnrA1 gene by means of PCR amplification. It was purified and labelled using a non-radioactive kit (ECL Direct Nucleic Acid Labeling and Detection System, GE Healthcare, Piscataway, NJ, USA). The incompatibility groups corresponding to the different plasmids were determined by means of PCR-based replicon typing, as described by Carattoli et al.
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Shotgun library construction and sequencing DNA from plasmid pSZ50 was purified by means of ion exchange columns (Qiagen), and it was randomly sheared by nebulization. The DNA library (2-5 kb) was constructed in the pJET2.1/Blunt vector using a CloneJET PCR cloning kit (Fermentas, Life Sciences, Glen Burnie, MD, USA). Plasmid DNA from the resulting subclones was purified prior to sequencing by means of the Wizard SV96 kit (Promega, Madison, WI, USA); sequencing was performed with a Big Dye Terminator kit (Applied Biosystems) using the MegaBACE 1000 and the ABI3100 sequencers (Applied Biosystems). Custom primers were also used when performing PCRs to extend the sequences of specific plasmids or to fill the gaps and ensure that double-strand data were obtained for the complete sequence of plasmid pSZ50. The tandemly duplicated nucleotide sequence was resolved by means of PCR amplification and sequencing. The data on the resulting sequences were assembled using the Phred/ Phrap/Consed software. 12 Annotation and analysis were performed using the VECTOR NTI program (Invitrogen, Life Technologies, Grand Island, NY, USA) and the tools available through the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/).
Analysis of the qnrA1 tandem duplication
The ISCR1-qnrA1-pse-1 tandem duplication was assayed by PCR amplifications using the Long PCR Enzyme Mix (Fermentas) with primers for ISCR1Fsec/ISCR1Rsec, QnrAFsec/QnrARsec and PSE-1Fsec/PSE-1Rsec, respectively (Table S1 and see Figure 3 ). Duplication of the qnrA1 gene was screened in a collection of qnrA1-positive isolates. 13 E. coli isolates 5509 and 14269 were included, respectively, as having two qnrA1 copies and one qnrA1 copy. In both isolates the plasmid content was purified by means of ion exchange columns (Qiagen). These plasmids were transformed into E. coli Top10F (Invitrogen) by electroporation, using standard conditions (Gene Pulser Xcell Electroporation System, Bio-Rad, Hercules, CA, USA). The MICs of several antibiotics in the presence of E. coli isolate 5509, as well as of different transconjugants or transformants, were determined by the microdilution method following the CLSI recommendations. 7 
Results and discussion
Characteristics of E. coli isolate 5509 E. coli isolate 5509 had a decreased susceptibility to nalidixic acid, ciprofloxacin and levofloxacin, and it was resistant to gentamicin, cefotaxime and ceftazidime. The ceftazidime susceptibility was recovered in the presence of clavulanic acid (.3-fold), suggesting the production of an ESBL ( Table 1 ). The qnrA1, qnrB2, aac(6 ′ )-Ib-cr and bla CTX-M-15 genes were identified by PCR and sequencing (Table 2) , whereas negative results were obtained for the qepA, bla SHV and bla TLA genes. Isolate 5509 harboured the 300 and ,5 kb plasmids and two incompatibility groups, namely IncF (positivity for repF, FIA, and FIB) and IncN, were found to be positive for the 300 kb plasmid ( Table 2 ). The incompatibility group of the ,5 kb plasmid was not identified. Apart from the presence of the three PMQR genes, no substitutions were detected in the gyrA and parC genes encoding the wild-type enzymes.
Distinct transconjugant phenotypes resulting from the mating-out experiments
The transfer of nalidixic acid, ciprofloxacin, ampicillin, cefotaxime, tetracycline, chloramphenicol and gentamicin resistance determinants was assayed at 30 and 378C by conjugation using E. coli 5509 as the donor strain. After the first mating (F1) experiments for each antibiotic were carried out, two transconjugant phenotypes were obtained (transfer frequency estimated at 1×10 24 ). All transconjugants (100%) selected in ampicillin, cefotaxime, ciprofloxacin, chloramphenicol and gentamicin showed only the phenotype A, displaying resistance to eight antibiotics (ampicillin, cefotaxime, nalidixic acid, ciprofloxacin, tetracycline, chloramphenicol, kanamycin and gentamicin) (F1-A). They were positive for the qnrA1, aac(6 ′ )-Ib-cr and bla CTX-M-15 genes, and they contained a single 300 kb plasmid, named pSZ300 (Table 2 and Figure 1a) . The transconjugants selected in nalidixic acid and tetracycline showed two phenotypes; 92% and 85% of transconjugants, respectively, showed the phenotype A (F1-A). However, 8% and 15% selected in nalidixic acid and tetracycline, respectively, showed the phenotype B, displaying resistance to three antibiotics (ampicillin, tetracycline and nalidixic acid) (F1-B); they were positive for the qnrA1 gene, and they harboured a 50 kb plasmid, named pSZ50 (Table 2 and Figure 1a) . The same phenotypes and transfer frequencies were observed under the two conditions (30 and 378C) in all antibiotics tested; nevertheless, at 378C the mating experiment was negative for tetracycline selection.
In order to identify whether those two plasmids maintained their self-transferability and integrity, a second-step mating-out experiment (F2) was performed using transconjugants F1-A (pSZ300) and F1-B (pSZ50) as donors, and selection was carried out on plates containing cefotaxime, nalidixic acid or tetracycline. When F1-A was used as the donor, the same resistance phenotypes (A and B) were obtained in similar proportions (100%/94%/91% and 0%/6%/9%) as those obtained with E. coli isolate 5509 (100%/92%/85% and 0%/8%/15%), regardless of the selection medium employed (cefotaxime, nalidixic acid and tetracycline), and the transconjugants were named F2-A and F2-B. When transconjugant F1-B encoding plasmid pSZ50 The phenotype A identified in the transconjugants selected in cefotaxime is identical to transconjugants selected in ampicillin, ciprofloxacin, chloramphenicol and gentamicin.
e Phenotype resistance: A: nalidixic acid, ampicillin, tetracycline, ciprofloxacin, cefotaxime, chloramphenicol, gentamicin and kanamycin; and B: nalidixic acid, ampicillin, and tetracycline.
f Detected by PCR; the mutation was confirmed by sequencing.
pSZ50, a conjugative plasmid resulting from the splitting of a 300 kb plasmid (qnrA1) was used as the donor, only the expected phenotype (B) was obtained (100%), including the qnrA1 gene and the 50 kb plasmid; it was named F2-BB (Table 2) . These results point out the self-transferability of plasmid pSZ50. Transfer frequencies in the mating experiments turned out to be higher (estimated at 1-2×10
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) than those observed in the case of the E. coli 5509 parental strain (F1) ( from E. coli and K. pneumoniae, respectively. The IncF and IncN incompatibility groups were identified in the E. coli isolate 5509 harbouring the 300 kb plasmid (pSZ300); these incompatibility groups were identified in all phenotype A transconjugants (F1-A and F2-A). On the other hand, in the case of phenotype B transconjugants (F1-B, F2-B and F2-BB) harbouring plasmid pSZ50, only the IncN incompatibility group was identified ( Table 2 ). The number of incompatibility groups associated with plasmid pSZ300 points to fusion of two replicons (cointegrate), as has been described previously. 16 In order to determine the MIC values for the different transconjugants harbouring plasmids pSZ300 and pSZ50, a susceptibility test was performed (Table 1) . For all transconjugants, the MIC value of nalidixic acid and levofloxacin displayed a 2-and 5-fold increase, respectively, in comparison with the E. coli recipient strain J53. The MIC of ciprofloxacin displayed a 6-fold increase for transconjugants harbouring plasmid pSZ300, which includes the qnrA1 and aac(6 ′ )-Ib-cr genes, and a 4-to 5-fold increase for transconjugants harbouring plasmid pSZ50, which includes the qnrA1 gene. This slight variation could be explained by the PMQR determinants included in each plasmid. The qnrB2 gene was not identified in any of the transconjugants, so we assumed that it is located in the chromosomal region. In addition, E. coli isolate 5509 showed no mutations in the gyrA and parC genes, which could confer resistance to fluoroquinolones. This genotype is in accordance with the MIC values of nalidixic acid, ciprofloxacin and levofloxacin, which are similar to those displayed in the case of the transconjugants. On the other hand, similar or identical results in terms of the MIC values in the case of b-lactam and aminoglycoside antibiotics were obtained for all transconjugants, which points to the integrity of plasmids pSZ300 and pSZ50 (Table 1) .
Identification of plasmid splitting
In order to identify whether plasmid pSZ50 is part of plasmid pSZ300, a restriction pattern and a subsequent hybridization using qnrA1 as a probe were carried out in both plasmids. The results revealed a similar restriction pattern in both of them, pointing to the fact that plasmid pSZ50 is indeed part of plasmid pSZ300 (Figure 1b) . The Southern hybridization showed that the qnrA1 gene was encoded in a shared 5.5 kb band present in both plasmids (Figure 1c) . Furthermore, the fact that the IncN incompatibility group was identified in all phenotype B transconjugants was in accordance with this observation (Table 2 ). These data underline that the 50 kb plasmid derived from the 300 kb plasmid and then transferred by conjugation as an independent replicon. In addition, the pSZ300 of the 300 kb plasmid (IncF and IncN) corresponds to a cointegrate, where the IncF replicon is defective to be transferred, as has been described in the pEK499 (IncF) plasmid, 16 and the pSZ300 plasmid requires a helper IncN plasmid (pSZ50) since no transformants carrying the IncF plasmid alone were observed.
General features of plasmid pSZ50
The complete nucleotide sequence of plasmid pSZ50 was obtained and then its genetic map was deduced. It was determined to be a 51 556 bp circular plasmid ( Figure 2 ) with a 52.7% G/C content. From the annotated data, 55 open reading frames (ORFs) were predicted, 50 of which encode proteins with previously described functions. Among the 55 ORFs, 6 are likely to play a role in the transposition and recombination processes. We also found that nine genes confer resistance to different antibiotics, including nalidixic acid (two copies of qnrA1), ampicillin (bla pse-1 ), streptomycin and spectinomycin (three copies of aadA2), tetracycline [tet(A)], trimethoprim (dfrA12), sulfamethoxazole (three copies of sul1) and ammonium quaternary compounds (three copies of qacED1) (Figure 2 ). The numbering of the plasmid starts at the repA and its iteron. The main regions of the antibiotic resistance genes include the following: (i) a 16826 bp region consisting of a complex sul1-type integron containing a class 1 integron, associated with the ISCR1-qnrA1-bla pse-1 -aadA2-qacED1-sul1 array and preceded by a tandem duplication from ISCR1 to qacED1-sul1, corresponding to 6314 bp ( Figures 2 and 3) ; (ii) a 20.1 kb region corresponding to a complete transfer region with an interruption of the tet(A)-terR genes (Tn1721 of 3417 bp); and (iii) a backbone sequence similar to the structure of plasmid pKP96 from the IncN group. 15 The antibiotic resistance-conferring genes that we identified were qnrA1, bla pse-1 and tet(A), responsible for the antibioticresistant phenotype B described above (nalidixic acid, ampicillin and tetracycline, respectively).
pSZ50 similarity
The plasmid pSZ50 was 99% identical to plasmid pKP96 (GenBank accession number EU195449) identified on E. coli and K. pneumoniae, respectively. 15 The gene arrays are very similar between both plasmids and correspond to genes related to repA (protein-initiated replication, incompatibility group IncN), stbA-B-C (plasmid instability), the tra operon (plasmid transfer) and tet(A)-tetR (tetracycline resistance), which are integrated in the fipA gene (Figure 2) . The ISCR1-qnrA1-pse-1-tniB-IS26 element integrated on pSZ50 corresponds to the same position of the ISCR1-qnrA1-pse-1-IS6100 element on pKP96 (Figure 3) . Nevertheless, the variable region of the class 1 In27 integron 17 contains the dfrA12, gcuF and aadA2 genes on pSZ50, instead of the aac(6 ′ )-Ib-cr present on plasmid pKP96. The complex sul1-type integron and its tandem duplication involving the qnrA1 gene constitute a major difference between them. The great similarities between the two scaffold sequences highlight that pSZ50 and pKP96 derive from a common ancestor. qacED1/sul1 ′ and 3 ′ regions preserved in the sul1-type integron. White arrows show the variable region of class 1 integrons, as well as the variable genes in the sul1-type integrons. The gene array of genes ISCR1 (orf513), qnrA1 and pse-1 is preserved in the class 1 integrons and is flanked by a second copy of the preserved 3 ′ region (qacED1-sul1). The tandem duplication and the flanking primers used for identification of duplication are shown. 1, ISCR1Fsec; 2, ISCR1Rsec; 3, qnrA1Fsec; 4, qnrA1Rsec; 5, PSE-1Fsec; and 6, PSE-1Rsec. pHSH1, E. coli (AY259085.1); 19 pKP96, K. pneumoniae (EU195449.1); 15 pQC, Enterobacter cloacae (AY987395.1); 20 pK9AT, Klebsiella oxytoca (AB469045.1). 21 hp, hypothetical protein.
qnrA1 gene: organization and contribution of qnrA1 copies
The sequence analysis revealed that the qnrA1 gene was located in a complex, tandemly duplicated sul1-type integron containing two regions. The first included a class 1 In27 integron, followed by a second sul1-type integron containing ISCR1, qnrA1, bla pse-1 and aadA2 as a constant gene array followed by a tandem duplication of the ISCR1, qnrA1, bla pse-1 and aadA2 genes, and qacED1-sul1 genes as a third copy ( Figure 3) . We considered the possibility of the qnrA1 duplication having had an effect on the increase in the MIC values in the case of quinolone and fluoroquinolone antibiotics. To elucidate this issue, we transformed the E. coli Top10F strain with two different plasmids: pSZ50 (two qnrA1 copies) and pHCG (one qnrA1 copy). The results showed no differences in terms of the MICs of nalidixic acid, ciprofloxacin and levofloxacin for either transconjugant. However, in comparison with the E. coli Top10F receptor strain, there was a 3-to 5-fold increase in terms of the MIC in the case of all the quinolones tested (Table 3) .
Conclusions
The incompatibility groups (IncF and IncN) identified for plasmid pSZ300 further suggested a fusion of two or more replicons, and it is plausible that the IncF plasmid carrying CTX-M-15 is defective in conjugation. The pSZ50-IncN plasmid mobilized to co-resident pSZ300-IncF plasmid providing additional antimicrobial resistances genes. The splitting of IncN plasmid (pSZ50) might result from an incidental event (cointegrate unstable), which involves the functional conjugation machinery; a DNA plasmid segment can be transferred through mating. The formation of this type of cointegrate is largely known; 18 however, this IncF-IncN cointegrate highlights the clinical implication of multiple antibiotic resistance genes. Nevertheless, the splitting of a DNA segment could be identified when some antibiotics, such as nalidixic acid and tetracycline, are used for counterselection in the process of bacterial conjugation. This mechanism could be advantageous in the dissemination of antibiotic resistance genes, including the In27 class 1 integron, the ISCR1-qnrA1-pse-1-aadA2 element tandemly duplicated and Tn1721 encoding tetracycline resistance. To understand the possible splitting mechanism of plasmid pSZ50 from plasmid pSZ300, further studies, including sequencing of the largest plasmid as well as genetic experiments including more antibiotics, will need to be performed.
Sequence data
The sequence data reported in this article appear in the GenBank/EMBL nucleotide database under accession number JN566044. pSZ50, a conjugative plasmid resulting from the splitting of a 300 kb plasmid
